Literature DB >> 10231146

Relapse of chronic myeloid leukaemia 14 years after allogeneic bone marrow transplantation.

A S Yong, J M Goldman.   

Abstract

Allogeneic bone marrow transplantation (BMT) is the treatment of choice for patients with chronic myeloid leukaemia (CML) who are relatively young and have suitable donors. Relapse is rare more than 5 years after allografting. We describe a patient who relapsed with myeloid blast transformation 14 years after allografting. This case suggests that leukaemia stem cells may on occasion remain quiescent for long periods and emphasises the importance of long-term follow-up after transplantation for CML.

Entities:  

Mesh：

Year:  1999        PMID： 10231146     DOI： 10.1038/sj.bmt.1701729

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  9 in total

1.  Relapse of chronic myeloid leukemia-chronic phase 14 years after allogeneic hematopoietic stem cell transplantation.

Authors:  Daigo Akahane; Yoshikazu Ito; Masahiko Sumi; Tetsuzo Tauchi; Yukihiko Kimura; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2008-05-30       Impact factor: 2.490

2.  Mechanisms of graft-versus-leukemia effects after allogeneic stem cell transplantation: effects on the leukemia stem cell?

Authors:  H-J Kolb; H Schmetzer; C Schmid; I Bigalke; R Buhmann; A Moosmann; C Falk; S Reuther; F Schuster; A Borkhardt
Journal:  Leuk Suppl       Date:  2014-12-17

3.  Late relapse of acute myelogenous leukemia followed by epstein-barr virus-associated lymphoproliferative disease 11 years after allogeneic bone marrow transplantation.

Authors:  Yoshikane Kikushige; Ken Takase; Toshihiro Miyamoto; Akihiko Numata; Kenjiro Kamesaki; Takahiro Fukuda; Koji Nagafuji; Hisashi Gondo; Mine Harada
Journal:  Int J Hematol       Date:  2006-12       Impact factor: 2.490

Review 4.  Treatment-free remission in patients with chronic myeloid leukemia.

Authors:  Delphine Rea; Jean-Michel Cayuela
Journal:  Int J Hematol       Date:  2017-07-08       Impact factor: 2.490

5.  Altered myelopoiesis and the development of acute myeloid leukemia in transgenic mice overexpressing cyclin A1.

Authors:  C Liao; X Y Wang; H Q Wei; S Q Li; T Merghoub; P P Pandolfi; D J Wolgemuth
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

6.  Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapy.

Authors:  Jaspal Kaeda; Derville O'Shea; Richard M Szydlo; Eduardo Olavarria; Francesco Dazzi; David Marin; Susan Saunders; Jamshid S Khorashad; Nicholas C P Cross; John M Goldman; Jane F Apperley
Journal:  Blood       Date:  2006-01-31       Impact factor: 22.113

Review 7.  The Emerging Picture of Human Breast Cancer as a Stem Cell-based Disease.

Authors:  César Cobaleda; Juan Jesús Cruz; Rogelio González-Sarmiento; Isidro Sánchez-García; Jesús Pérez-Losada
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

8.  Clinical and biological predictors of outcome following relapse of CML post-allo-SCT.

Authors:  Natasha A Jain; Sawa Ito; Xin Tian; Roger Kurlander; Minoo Battiwalla; Kit Lu; Bipin N Savani; Vera Malkovska; Katayoun Rezvani; Robert Q Le; Aarthi Shenoy; Christopher S Hourigan; Keyvan Keyvanfar; Eleftheria Koklanaris; Jeanine Superata; Pawel Muranski; A John Barrett; Agnes S M Yong
Journal:  Bone Marrow Transplant       Date:  2014-11-10       Impact factor: 5.483

9.  Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation.

Authors:  Håkon Reikvam; Jørn Skavland; Stein-Erik Gullaksen; Randi Hovland; Tobias Gedde-Dahl; Øystein Bruserud; Bjørn Tore Gjertsen
Journal:  Case Rep Hematol       Date:  2018-09-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.